Biological & Psychological Factors as Predictors & Indicators of MBSR Response

生物

• 批准号: 8496498
• 负责人: STEVAN HOBFOLL
• 金额: $ 43.75万
• 依托单位: RUSH UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-01 至 2016-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8496498
• 关键词: Address; Advocate; Agreement; Anxiety; Biologic Characteristic; Biological; Biological Factors; Characteristics; Chronic; Chronic Disease; Clinical; Clinical Research; Complementary and alternative medicine; Data; Disease; Disease Marker; Disease Outcome; Disease Progression; Effectiveness; Enrollment; Ensure; Flare; Funding; Goals; Health; Individual; Inflammation; Inflammatory; Inflammatory disease of the intestine; Injury; Intervention; Intestines; Lead; Life; Link; Literature; Manuals; Measurable; Measures; Mediating; Mind-Body Intervention; Modeling; Modification; National Center for Complementary and Alternative Medicine; Organ failure; Outcome; Outcome Measure; Pathway interactions; Patient Selection; Patients; Personal Satisfaction; Physiological; Process; Protocols documentation; Psychological Factors; Quality of life; Questionnaires; Randomized; Recruitment Activity; Relapse; Reporting; Selection for Treatments; Signal Pathway; Stress; Symptoms; Therapeutic; Tissues; Treatment Protocols; Ulcerative Colitis; base; biological adaptation to stress; body-mind; cohort; design; disease characteristic; improved; innovation; mindfulness; mindfulness-based stress reduction; prevent; psychologic; response; stressor; success; tool; trait

DESCRIPTION (provided by applicant): The overall goal of this RO1 project is to develop and validate a set "platform" of biological and psychological characteristics (i.e., biopsychomarkers) that predict and indicate patient (Pt) response to mindfulness-based stress reduction (MBSR) and verify that a tailored MBSR approach improves the quality and consistency of MBSR on disease outcomes. Our preliminary data demonstrate that only a subset of ulcerative colitis (UC) Pts respond to MBSR with improved disease outcomes which is in agreement with the literature which reports similar mixed outcomes with mindfulness therapy when it has been applied to other diseases, suggesting that certain biopsychomarkers may impact success. Thus, we hypothesize that the differential responses to MBSR are a consequence of individual variance in biopsychomarkers at the onset of MBSR therapy. The objective of the current proposal is then to identify and verify predictive biopsychomarkers and reliable measurable outcomes as determinants of MBSR success. To achieve this objective we propose two Specific Aims. Aim1: Develop a set of biopsychomarkers, comprised of key psychological and biological characteristics that (a) predict UC Pt response to MBSR and (b) establish an objective set of markers that demonstrate the impact of MBSR on well-being and UC disease state. Aim 2: Verify the impact of Pt and intervention tailoring in order to determine whether (a) tailoring Pt selection based on biopsychomarkers, and whether (b) tailoring of MBSR treatment protocol will impact MBSR's effects on inflammatory pathways and markers of disease and psychological well-being in UC Pts. Accomplishing these Aims will establish an objective set of Pt characteristics that predict effectiveness of MBSR resulting in increased quality and consistency of MBSR as a therapeutic approach. This should open new innovative therapeutic applications for MBSR for the treatment of chronic inflammatory diseases.

描述（由申请人提供）：本RO1项目的总体目标是开发和验证一套生物和心理特征的“平台”（即，生物心理标志物），其预测和指示患者（Pt）对基于正念的减压（MBSR）的反应，并验证定制的MBSR方法改善了MBSR对疾病结果的质量和一致性。我们的初步数据表明，只有一部分溃疡性结肠炎（UC）患者对正念减压疗法有反应，疾病结局得到改善，这与文献报道的正念疗法应用于其他疾病时的类似混合结局一致，表明某些生物心理标志物可能会影响成功。因此，我们假设对正念减压疗法的不同反应是正念减压疗法开始时生物心理标志物个体差异的结果。目前的建议的目的是识别和验证预测生物心理标志物和可靠的可测量的结果作为正念减压疗法成功的决定因素。为了实现这一目标，我们提出了两个具体目标。目标1：开发一组生物心理标志物，包括关键的心理和生物学特征，（a）预测UC Pt对MBSR的反应，（B）建立一组客观的标志物，证明MBSR对健康和UC疾病状态的影响。目标二：验证患者和干预措施定制的影响，以确定（a）是否基于生物心理标志物定制患者选择，以及（B）是否定制MBSR治疗方案将影响MBSR对UC患者的炎症通路和疾病标志物以及心理健康的影响。实现这些目标将建立一组客观的Pt特征，预测MBSR的有效性，从而提高MBSR作为治疗方法的质量和一致性。这将为正念减压治疗慢性炎症性疾病开辟新的创新治疗应用。